Stability of warfarin solutions for drug–protein binding measurements: Spectroscopic and chromatographic studies
Authors:
- David S. HageDHDavid S. Hage
- 1 June 2006
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 41 (4) , 1101-1109
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Analysis of Free Drug Fractions by Ultrafast Immunoaffinity ChromatographyAnalytical Chemistry, 2001
- Site I on human albumin: Differences in the binding of (R)- and (S)-warfarinChirality, 1999
- Chiral Separation Mechanisms in Protein-Based HPLC Columns. 1. Thermodynamic Studies of (R)- and (S)-Warfarin Binding to Immobilized Human Serum AlbuminAnalytical Chemistry, 1994
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989
- Current concepts of warfarin therapyArchives of internal medicine (1960), 1986
- Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.Circulation, 1985
- Current status of pulmonary thromboembolic disease: Pathophysiology, diagnosis, prevention, and treatmentAmerican Heart Journal, 1982
- Vitamin K and the Oral Anticoagulant DrugsAnnual Review of Medicine, 1976
- The crystal and molecular structure and absolute configuration of (−)-(S)-warfarinActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1975
- Carbon-13 Nuclear Magnetic Resonance Spectroscopy. Structure of the Anticoagulant Warfarin and Related Compounds in SolutionProceedings of the National Academy of Sciences, 1974